Reply to: Adjuvant Carboplatin for Early-Stage, Triple-Negative Breast Cancer: Taxane and Patient Selection
Journal of Clinical Oncology · 20.08.2026 · 44 (24) · 2357-2358
DOI: 10.1200/jco-26-00605 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Oncology, erschienen am 20.08.2026. Verfasst von Haoting Shi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Haoting Shi, MD; Jiahui Huang, MD; Xiaosong Chen, MD; and Kunwei Shen, MD; Department of General Surgery, Comprehensive Breast Health Center, Ruijin …. Die Arbeit nennt 9 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Haoting Shi, MD; Jiahui Huang, MD; Xiaosong Chen, MD; and Kunwei Shen, MD; Department of General Surgery, Comprehensive Breast Health Center, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai,…
ORCID-Profile: Haoting Shi, Xiaosong Chen, Kunwei Shen
Zitieren
APA
Shi, H., Huang, J., Chen, X., & Shen, K. (2026). Reply to: Adjuvant Carboplatin for Early-Stage, Triple-Negative Breast Cancer: Taxane and Patient Selection. Journal of Clinical Oncology, 44(24), 2357-2358. https://doi.org/10.1200/jco-26-00605
Vancouver
Shi H, Huang J, Chen X, Shen K. Reply to: Adjuvant Carboplatin for Early-Stage, Triple-Negative Breast Cancer: Taxane and Patient Selection. Journal of Clinical Oncology. 2026;44(24):2357-2358. doi:10.1200/jco-26-00605
BibTeX
@article{Shi2026,
author = {Shi, Haoting and Huang, Jiahui and Chen, Xiaosong and Shen, Kunwei},
title = {Reply to: Adjuvant Carboplatin for Early-Stage, Triple-Negative Breast Cancer: Taxane and Patient Selection},
journal = {Journal of Clinical Oncology},
year = {2026},
volume = {44},
number = {24},
pages = {2357--2358},
doi = {10.1200/jco-26-00605}
}
EUVIMED